Parkinson's disease is second most common neurodegenerative disorder neurological
illness that primarily affects patients in their later years of life. Specific neurons in the brain …

Background Both motor and non-motor symptoms of Parkinson's disease (PD) have a
substantial detrimental influence on the patient's quality of life. The most effective treatment …

Parkinson's disease (PD) is the second most prevailing neurodegenerative disorder and is
indicated by the degeneration of dopaminergic neurons within the substantia nigra; various …

Background: After Alzheimer's disease, the second slot for the most common
neurodegenerative disease, is occupied by Parkinson's disease. The symptoms of …

During the last few decades, there has been a remarkable progress in our understanding of
the biology of Parkinson's disease (PD), which has been translated into the development of …

Parkinson disease is a chronic, progressive neurodegenerative movement which affects
about 1% of population over the age of 60. In Parkinson disease there is loss of …

ABSTRACT Parkinson′ s disease (PD), the second neurodegenerative disease in the
world, is characterized by a combination of motor symptoms (rest tremor, bradykinesia …

Parkinson's Disease (PD) is the second most common neurodegenerative disease in the
elderly population, with a higher prevalence in men, independent of race and social class; it …

Parkinson's disease (PD) is the second most common neurodegenerative disease. The
prevalence is increasing with age and averages approximately 0.3% in the entire …

Over the decades, pharmaceutical treatments, particularly dopaminergic (DAergic) drugs
have been considered as the main therapy against motor symptoms of Parkinson's disease …